[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-INBX":3,"homepage-market-summary":31,"stock-news-INBX":173},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"INBX","2026-10-05",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Inhibrx Biosciences, Inc. Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.","110","La Jolla, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},94.56,97.56,98.5054,94.18,96.99,-2.43,-2.51,206566.080506,6636,95.6618,155.28999,28.16,340032.21861718723,52.2,1539,{"status":32,"indices":33,"watchlist":76,"sectors":98,"benchmarks":153},"success",[34,42,49,56,63,69],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7773.95,51.23,0.66,true,"0.0,8.3 2.3,10.7 4.6,13.5 6.9,9.4 9.3,11.7 11.6,13.9 13.9,16.0 16.2,10.6 18.5,9.8 20.8,2.6 23.2,2.6 25.5,6.3 27.8,6.4 30.1,3.9 32.4,7.7 34.7,8.5 37.1,9.7 39.4,8.8 41.7,5.2 44.0,2.0",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",31076.44,268.51,0.87,"0.0,12.3 2.3,12.8 4.6,14.9 6.9,13.2 9.3,14.8 11.6,16.0 13.9,16.0 16.2,12.7 18.5,11.4 20.8,5.9 23.2,4.3 25.5,6.0 27.8,5.9 30.1,5.1 32.4,7.2 34.7,6.8 37.1,6.4 39.4,5.8 41.7,3.8 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51268,91,0.18,"0.0,2.0 2.3,5.0 4.6,7.4 6.9,3.6 9.3,4.7 11.6,7.2 13.9,11.9 16.2,9.5 18.5,10.2 20.8,7.5 23.2,8.9 25.5,11.5 27.8,12.7 30.1,9.1 32.4,11.7 34.7,12.7 37.1,16.0 39.4,15.8 41.7,14.0 44.0,13.3",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27477.31,286.45,1.05,"0.0,11.9 2.3,13.4 4.6,15.0 6.9,12.7 9.3,14.1 11.6,16.0 13.9,16.0 16.2,11.9 18.5,10.9 20.8,5.3 23.2,4.2 25.5,7.1 27.8,7.0 30.1,5.8 32.4,8.1 34.7,8.3 37.1,7.8 39.4,7.7 41.7,4.7 44.0,2.0",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":39,"is_up":40,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2833.8,18.6,"0.0,2.0 2.3,5.4 4.6,7.8 6.9,6.8 9.3,8.3 11.6,10.0 13.9,11.0 16.2,9.7 18.5,10.8 20.8,9.6 23.2,8.2 25.5,12.6 27.8,12.9 30.1,12.6 32.4,14.2 34.7,15.1 37.1,16.0 39.4,15.1 41.7,13.0 44.0,11.4",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":40,"sparkline":75,"date":5},"VIX","CBOE VIX",15.52,0.21,1.37,"0.0,10.2 2.3,7.3 4.6,2.0 6.9,9.7 9.3,4.9 11.6,4.5 13.9,2.5 16.2,11.3 18.5,13.7 20.8,13.5 23.2,16.0 25.5,12.3 27.8,10.4 30.1,13.5 32.4,8.8 34.7,8.9 37.1,7.8 39.4,7.6 41.7,11.8 44.0,10.9",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":40,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",238.9,4.95,2.12,"0.0,16.0 7.3,12.2 14.7,13.8 22.0,12.6 29.3,10.1 36.7,7.0 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":14,"sparkline":90,"date":5},"AAPL","Apple Inc",332.89,-0.8,-0.24,"0.0,2.0 7.3,5.2 14.7,16.0 22.0,11.7 29.3,14.9 36.7,10.9 44.0,11.8",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":40,"sparkline":97,"date":5},"TSLA","Tesla Inc",378.69,8.1,2.18,"0.0,5.6 7.3,13.5 14.7,16.0 22.0,14.9 29.3,15.3 36.7,6.4 44.0,2.0",[99,104,109,114,119,124,129,134,139,144,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":40},"Technology","XLK",0.56,200.93,{"name":105,"etf":106,"change":107,"price":108,"is_up":40},"Financials","XLF",0.73,53.88,{"name":110,"etf":111,"change":112,"price":113,"is_up":40},"Healthcare","XLV",0.72,167.37,{"name":115,"etf":116,"change":117,"price":118,"is_up":40},"Consumer Cycl","XLY",0.35,110.42,{"name":120,"etf":121,"change":122,"price":123,"is_up":40},"Consumer Staples","XLP",0.63,81.04,{"name":125,"etf":126,"change":127,"price":128,"is_up":40},"Energy","XLE",0.99,63.44,{"name":130,"etf":131,"change":132,"price":133,"is_up":40},"Industrials","XLI",0.09,170.1,{"name":135,"etf":136,"change":137,"price":138,"is_up":40},"Materials","XLB",1.31,49.5,{"name":140,"etf":141,"change":142,"price":143,"is_up":14},"Real Estate","XLRE",-0.34,40.67,{"name":145,"etf":146,"change":117,"price":147,"is_up":40},"Utilities","XLU",39.97,{"name":149,"etf":150,"change":151,"price":152,"is_up":40},"Comm Services","XLC",1.17,111.61,[154,159,164,169],{"ticker":155,"name":156,"price":157,"change":158,"is_up":40},"SPY","SPDR S&P 500 ETF",774.83,0.67,{"ticker":160,"name":161,"price":162,"change":163,"is_up":40},"QQQ","Invesco QQQ Trust",756.2,0.88,{"ticker":165,"name":166,"price":167,"change":168,"is_up":40},"DIA","SPDR Dow Jones ETF",512.11,0.2,{"ticker":170,"name":171,"price":172,"change":39,"is_up":40},"IWM","iShares Russell 2000",283.39,{"ticker":4,"count":174,"articles":175},19,[176,182,188,193,199,205,211,216,222,228,234,240,245,250,255,260,265,270,276],{"title":177,"link":178,"pubDate":179,"description":180,"source":181},"Inhibrx Stock Price Forecast. Should You Buy INBX? - StockInvest.us","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiSEFVX3lxTE1kclhsU2xMcHc0X1Bzd2wtZF9TazhCejZQck5ycFpDVkpONTg0VHBWR283MjZNbVExZ1pDVDhuMXJxY2NQRHQwbg?oc=5","Fri, 02 Oct 2026 22:22:43 GMT","Inhibrx Stock Price Forecast. Should You Buy INBX? StockInvest.us","StockInvest.us",{"title":183,"link":184,"pubDate":185,"description":186,"source":187},"$INBX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiowFBVV95cUxPYmY5ZXhTNjQwTk1nS3A0cTV4Vm01ZWd3cUZsRlZ1MTl1dnBqRVU1b1hlYklSLXZrMThCWGc1QXBKaGw5S1Q2S1BiV0FWTlJtNUgzZENxeGEtTkRpeHVkM3o5bzhBQ3VKRDJ4YXZNYVBORXAyWUxqSDQtdFR5bUhTQ2dMdGJCMUxTaHUtWXA0VlBwNlZyUG5OS3N1WGM1b0FZd3RF?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","$INBX stock is down 11% today. Here's what we see in our data. Quiver Quantitative","Quiver Quantitative",{"title":189,"link":190,"pubDate":185,"description":191,"source":192},"At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxPU0NyWDJTQm94X0FWLWpBYVNmNDVjUkxNd3IxdVdqMlhKX1VOaTBYWEFBVUk0UE9zR3RpZ2gzdVdaeWlPXy1ibGxJbFpKNExGMl9vRGxGRnNzejJiRjBSTzBLM3BfRVg0VWR5akxiRW9sODFkMTlWRllGc0RXYUh2Ujk1S2JMRVZ5UWxkdWNPQXJTZXJqSWszYThGZkJ3SFFfZnFtb1MtLWpReUE1a0twRXJOTEZNWHNZ?oc=5","At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX). Stock Titan","Stock Titan",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6AFBVV95cUxOS1R6d08zQTQtTHJ3dnZoVFNZT0JpbnlWWTBXcEQzS0RRQUJzNHZ4NERWb1J0TGdJQVhMYTVkajZnSWFodl9kWG5HY18yd3RZNXVJcEdyTC1ZdnY2R2xPenJuNURZelZySXlHbU9QYjdUXzdJUmFkei1EaW9WX0RVWEVSa0lLTmR4YnE5TVJDS3c0MDNvMlM4LUw0WkF0OTk3XzVpUVd1N2ptV2N6RGFrSDA5ZWxZS2dIVzE4WTVlVUFucWp0cE1KbXZoUFBlNERyU1poWE1QNURGVHRFZXQwcUM4YWRKWkxJ0gHuAUFVX3lxTE9JQVBfQVgybXkyTGs3aVRFS1NheHh0aFpXS3U0bjZYRUxmTUV4LUtiejNDZnhXV3NtRmIwc29BTFRMaWNtZy1fLUtyV19qSVVuRVZpMHo3VUNoSEY5ZGVDRXpNd0pUdVBMUVlCM0w5WXV1NUprUEltMXVYelpTTXluTm9hbG9TamtObXF6MTNYcklfQ0VwTF9SeEdiM1VydnIxaW1ZYkJVZjhJMFhaMGRVOVBjRHpZSnc0cm1INFFoenpMRm5YQmhHaHNvZG1JdzYtZk9lQlhkYVg1akRvM29YN2ZHaUZhSXdQWHFuN0E?oc=5","Tue, 29 Sep 2026 15:15:03 GMT","Inhibrx Biosciences (INBX) Shares Moved, What Is Driving Attention Now? Simply Wall Street","Simply Wall Street",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxON2hFMEdyRWNmcnNhRmdzWFE0a0tiQ0xLQ2FiOWtGWTdtdUpseDBiTGJzRnhoSng4Slc5RlU2QXJSM3pUNjdVMnlZNWNpWG4weVp0QUs2VE1wa3ZTYmFSZDhiNVRvX21wREVjLXpZTzhsN3hjZXBfSTNnYUVPRUg5TUtCbzg1NjBjVXdPaGNnUmFldXZqRGZ6OTR6c01LeHBpMEd6Tm81R3F0TTZqSUE?oc=5","Fri, 02 Oct 2026 12:10:50 GMT","Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup MarketBeat","MarketBeat",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Inhibrx Biosciences (INBX) Faces A Pipeline Valuation Test Following Its Sharp Rerating - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipwFBVV95cUxNRUxoQURNZW5RaTRZZnBWcXVRbEx2S18wd2lDdXlIdmphbFBYTlZBcWJrcHFvNFM3Ry1YNDE1LWZFdXItVDlZX3hvOHRkdjZKOGxSdjZVY2tzYk5qQlh0TGY3XzUzUU9JRUhsUjZjTnRlNFpzYXgwc05CajZNZVV2bFJaSmhyMmZHcC1SUFE3T0RKLTRSVjNwajhlQnR0dXY0UGdXSUtmRQ?oc=5","Tue, 29 Sep 2026 11:08:51 GMT","Inhibrx Biosciences (INBX) Faces A Pipeline Valuation Test Following Its Sharp Rerating Yahoo Finance","Yahoo Finance",{"title":212,"link":213,"pubDate":214,"description":215,"source":192},"Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxPVER0R0F1bFRFNGJmWnFERkRaSmtyOE1LcUlfR3hjOHJzNWdyMlJiOGlVM3BDWUpKYjhuajN1cjNKdU02NWc5MDBnRTB3S2NIZ0pHVnpSTVAyYVhrU3BXa0tyR1hLU0hreEFVYk5lRHBuUXhFUzVyREJ6X0Ixcm1JQVpZX2tBX2JkQVM0Z1Z2eW1tQUNTR1lqNGtrODB1ak9pREVxRF9NQklDWFVwY1VHMG1Xc0Z6SFlK?oc=5","Mon, 28 Sep 2026 21:48:57 GMT","Four purchases over two days: Inhibrx Biosciences (INBX) CEO's family trust bought 10,000 shares. Stock Titan",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxNZVNQcFBhNER0NXpVT2pJR0xBUC1YSmt1QzlKX19MdHdNQVI0dF9nMExjY1Fzd0d1U0NlZWt1Y3MxZW5QRVptSFNqYmtGOTFYMUk3TmNZNkJqOXdZTmRVUmN2WlE3SjBLd1RkZFJoNnZVWS1WZVoxRWVUQ1NsOG9wQU8wdDdVMVV5dXdRMDZ4YUxyWG1JbnZlWEdzWE9qSmQ3SDF1ZmVrTURnNGo4Q2xFU2Uzb2N6d2VXaHpQc1YxcUdOQ0U0?oc=5","Mon, 28 Sep 2026 22:49:35 GMT","Inhibrx Biosciences CEO Mark Lappe buys $998k in company stock Investing.com","Investing.com",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"INBX Oct 2026 90.000 put (INBX261016P00090000) Stock Price, News, Quote & History - ca.finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTE5WM3dqNlliU1BQVC1pNklmdy1sQkRiamVRYXR5LWdDQ1VLZmtZOG81N0VqZElleGh0Vkc5bzJxY2xvQnRBNk1BM01PMzRLcDZGZEp6aDUzLTV4aHNBX044TlFnVWlSUQ?oc=5","Wed, 30 Sep 2026 14:57:20 GMT","INBX Oct 2026 90.000 put (INBX261016P00090000) Stock Price, News, Quote & History ca.finance.yahoo.com","ca.finance.yahoo.com",{"title":229,"link":230,"pubDate":231,"description":232,"source":233},"Inhibrx Biosciences stock gains on insider buying and trial progress - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxOWmlHbHJmOU9aWTNYWDljazFkUV8xYlJiNDRzT0tjc2tWNW9lMzFfQ2hvTFZ0dUx5ekg5eXo3QmZrOVJFRE5BRjFsNFZCVWdySk5USUFOZ3JhSXRseDR0TEh2RlNvMnBiTGxnc3dxemFUUDAwUnhlRGttM0x2ZTRKNUk5d0pxd0QzR1ZaZVF5cmk0bllqb2tZdnp4cFJfLWFFWXJEb3hTUU9IaG9FcUJxWTVxRUFhbzBPS2VjQ2JFTmFGVjNoLXc?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","Inhibrx Biosciences stock gains on insider buying and trial progress AD HOC NEWS","AD HOC NEWS",{"title":235,"link":236,"pubDate":237,"description":238,"source":239},"Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing - marketscreener.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxQbUR2ME1MYkE1SnNTbTg3SUp6ZGlPYWZWZTk2VDh5ZXhvaS1YN2x1MzBXSzMwdWlaR3Z0Sy1YckdtOUFxUDZLMVh2OUt3NTQtWkNlekRKRHg4X0YwOXgyRDRjZHBvUUN6OHk4a3JLd0hkSjU5Z1p4dGNzMFpvbTlSR25aWnhHOTdxMDdfR0FiRlJqcFA1NFRrQ0RmbE93a2lxSnBXUURqMzZSZ1BmcHpRZEhfVUw3OUZhbmhsLTNCZDFYeGlRQlpKREptSHlCbUZMZ2tCTGsyQm8?oc=5","Wed, 23 Sep 2026 21:02:33 GMT","Inhibrx Biosciences Insider Bought Shares Worth $500,000, According to a Recent SEC Filing marketscreener.com","marketscreener.com",{"title":241,"link":242,"pubDate":243,"description":244,"source":192},"A bone cancer drug met its trial goal for Inhibrx Biosciences (INBX), delaying progression versus placebo. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxQWVRYUFhENU9nXzRNd3YzZzNUSktpLVU4R2l4SEFlNkd2RU1EZTYyM29MTlUyMzFuZGJwdGVmM1Fsd1NDaUJWVk40Z3U2SFloekpwNUExSEI1QVhrTVNEdjFXRlFWU3ZzVm5VZlRUam1jN0dXSko1d18tTEN2SE51SG5IZEFpZ05RX0FLaDF2NlR2ZU5jV3pyMHlLbFhEOVgwNEZRNDRkam52LXhPWlhGM0Rn?oc=5","Mon, 28 Sep 2026 21:04:48 GMT","A bone cancer drug met its trial goal for Inhibrx Biosciences (INBX), delaying progression versus placebo. Stock Titan",{"title":246,"link":247,"pubDate":248,"description":249,"source":227},"CPB,AHRT,NPWR,BSIN,INBX,VRSK,AMPG | Stock Prices | Quote Comparison - ca.finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiekFVX3lxTE5LbUxQRzZYQ1Q3U1c1aFFHQnFrSHB4OTNjWUJpNEJwY08yb016Y183c3pKeDZEZVY0Vng0MUpXUmtQMXBQQTRxMzctSWlveVZtTWlfd2dCU3ZvdUMwN3dDQUpXUTNpaU8zYVhUZElyZm1mQUZqSjBUX01R?oc=5","Thu, 01 Oct 2026 10:27:29 GMT","CPB,AHRT,NPWR,BSIN,INBX,VRSK,AMPG | Stock Prices | Quote Comparison ca.finance.yahoo.com",{"title":251,"link":252,"pubDate":253,"description":254,"source":233},"Inhibrx updates pipeline data as analysts rate Inhibrx stock Moderate Buy - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxPVFVEN0drTWduM1FVd1BRTHVUYzB4czVvelpIeTlmT2hnYU1pek0yYzR4MHJmQ05QTVh3UUxNbUtpZGJ3SUZmWVRvNm9WUXNWRDFtbXBtaW5ieWo4T29URXh3eTRGS1ZhbHIzQk1iWi1PbGs3U0c0NEtoQ0tMdlhQcGtVclZxQ0xERjdlWjNtcllMM0JOYjQyc1p2azVRQk1WdGlLLW9iMlR1SEJBY0RWNFo1Y2xSMENxVEVPcWNUbGRFYjJzclpDQ2E0eEw?oc=5","Mon, 05 Oct 2026 11:38:22 GMT","Inhibrx updates pipeline data as analysts rate Inhibrx stock Moderate Buy AD HOC NEWS",{"title":256,"link":257,"pubDate":258,"description":259,"source":233},"Inhibrx Biosciences stock reports stronger cancer study data - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxPSHJiVzJCeTc1Rk5QT1NlYmpQSGgzQXVwSXZCN1ZCX2RWZmFmT09PbVlXbjZRVXlBVE1tRDF5VnQzQXRMUFNjV2dtdHlkWTQ5V285OXk3Y21qX1RLNGJRc0F6ejFBOEw5TkxKWV8yVkZQbmdDSUloRWZqeGdIVkw5ZVkyNUo2cDZHUFNpOXNsV041eFZZRXFGOUtzMjFlVTUxd3JJMUNNeWNEdVhRQ0l3eGpjZ1VkVHUyVnNn?oc=5","Fri, 25 Sep 2026 12:33:40 GMT","Inhibrx Biosciences stock reports stronger cancer study data AD HOC NEWS",{"title":261,"link":262,"pubDate":263,"description":264,"source":233},"Inhibrx Biosciences stock falls 1.62 percent on October 5 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQaWRoWTdjVGtzcVVrc1VTb1dlUUs1a2dieGlVOGVxaV9tTGQxNHZVMlNoTnRMclFMRWw2YlE0Wlp0V1paZGE5cUtvWDFFV2pnZGtLOWhRc1ZpUkVlcXc4WDFKcHBhLWw3LVpQQ0JHRGYwaF9TZ1RuVFI2NFgzQkxMSjFHUDV2R2wzTTdWeFpQSkVBSk14cENKNHc1UFZIaXI0cmZpcHN5TXJQdk1IUUFPTjIzQUpzdkhpWXVzOQ?oc=5","Mon, 05 Oct 2026 15:19:22 GMT","Inhibrx Biosciences stock falls 1.62 percent on October 5 AD HOC NEWS",{"title":266,"link":267,"pubDate":268,"description":269,"source":233},"Inhibrx Biosciences stock gets a Moderate Buy consensus at USD 197.50 - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxPaUpZUHhlQi0yM2NBZFpYYXl3cnY4bVItcVh0ZlJpU1VFMEV6dFE5Tkg1N1FBdFZTR0w2bVprbUhta2tnTk9WZ09aZDN2cmZTVmhWWi1EWTVSUTZWaXFMT3lkNm1lSWdJQmlRTVRMa0pzUUVQUEhadFZJeUhibzgxNEFpZGNqdG96aDU4clZlNTN4VXgzN3dqb25TS1VhYy1fcjZ2OXlEanhEU2FtYTJ4dVliX3VsU2NweGxXeHR5eGUzekxPODF2MHZXcDU?oc=5","Sun, 04 Oct 2026 10:52:50 GMT","Inhibrx Biosciences stock gets a Moderate Buy consensus at USD 197.50 AD HOC NEWS",{"title":271,"link":272,"pubDate":273,"description":274,"source":275},"Inhibrx Biosciences Updates Investor Presentation and Pipeline Outlook - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQSkEwRXFPaDh2VTFFQkYtTnNOdktYTDkzeHQ4RkxfbjM0Y0JVU3BLVGloZGMzTnRVQW1FYzYxZnExOGVaVWQyMmNkZk9Lcm9kb0VZZHNKUFlqcUVtcE05UmI0ZmJETDBuSkVwV0l0SFlKajl5Z0dtUktDRUxScklLczVpM25SeGlOaVdBVzNDQXhxUlNZRklGSXp4UGNHRExjemdDM1NmUVRfb3kxMENuNGNuLW4xakQ2X2RMV2JUSQ?oc=5","Mon, 28 Sep 2026 21:44:46 GMT","Inhibrx Biosciences Updates Investor Presentation and Pipeline Outlook TipRanks","TipRanks",{"title":277,"link":278,"pubDate":279,"description":280,"source":281},"Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? - Insider Monkey","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall? Insider Monkey","Insider Monkey"]